AMPE Insider Trading Activity and SEC Form 4 Filings
AMPE insider trading summary
No open-market insider purchases or sales of Ampio Pharmaceuticals, Inc. (AMPE) have been reported on SEC Form 4 in the past 12 months.
Latest AMPE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 9, 2023 | J Kevin Buchi | Director | Buy | $6K (21,858 @ $0.29) |
| Jun 8, 2023 | J Kevin Buchi | Director | Buy | $7K (25,000 @ $0.30) |
| May 24, 2023 | Michael A Martino | CEO | Buy | $22K (76,890 @ $0.29) |
| May 16, 2023 | J Kevin Buchi | Director | Buy | $9K (32,534 @ $0.27) |
| May 15, 2023 | J Kevin Buchi | Director | Buy | $11K (44,026 @ $0.25) |
| May 12, 2023 | David R Stevens | Director | Buy | $10K (45,000 @ $0.22) |
| May 12, 2023 | J Kevin Buchi | Director | Buy | $6K (23,440 @ $0.24) |
| May 11, 2023 | David R Stevens | Director | Buy | $6K (25,000 @ $0.22) |
| May 11, 2023 | David R Stevens | Director | Buy | $5K (25,000 @ $0.21) |
| Jun 25, 2021 | Dan Stokely | CFO | Sell | $40K (22,500 @ $1.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.